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Abstract
Treatments to improve the neurological outcome of edema and cerebral ischemic stroke are severely limited. Here, we
present the first in vivo single cell images of cortical mouse astrocytes documenting the impact of single vessel
photothrombosis on cytotoxic edema and cerebral infarcts. The volume of astrocytes expressing green fluorescent protein
(GFP) increased by over 600% within 3 hours of ischemia. The subsequent growth of cerebral infarcts was easily followed as
the loss of GFP fluorescence as astrocytes lysed. Cytotoxic edema and the magnitude of ischemic lesions were significantly
reduced by treatment with the purinergic ligand 2-methylthioladenosine 59 diphosphate (2-MeSADP), an agonist with high
specificity for the purinergic receptor type 1 isoform (P2Y1R). At 24 hours, cytotoxic edema in astrocytes was still apparent
at the penumbra and preceded the cell lysis that defined the infarct. Delayed 2MeSADP treatment, 24 hours after the initial
thrombosis, also significantly reduced cytotoxic edema and the continued growth of the brain infarction. Pharmacological
and genetic evidence are presented indicating that 2MeSADP protection is mediated by enhanced astrocyte mitochondrial
metabolism via increased inositol trisphosphate (IP3)-dependent Ca
2+ release. We suggest that mitochondria play a critical
role in astrocyte energy metabolism in the penumbra of ischemic lesions, where low ATP levels are widely accepted to be
responsible for cytotoxic edema. Enhancement of this energy source could have similar protective benefits for a wide range
of brain injuries.
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Introduction
Brain edema and infarctions result from multiple insults, but are
typically preceded by cytotoxic edema [1,2,3]. Cell swelling is most
prominent in astrocytes and appears to be initiated by Na+
accumulation due to failure of energy dependent ion extrusion [2].
ATP levels are depleted since oxidative phosphorylation is
abrogated during ischemia or hypoxia [4]. Brain swelling is
generally attributed to vasogenic edema caused by breakdown of
the blood-brain barrier (BBB) and accumulation of extracellular
water [1,4]. Astrocyte necrosis subsequent to osmotic expansion
damages adjacent tissue and expands the infarct by secondary
mechanisms [4,5,6]. The expanding infarction core with a
dynamic peri-infarct penumbra is not yet irreversibly injured
and consequently, serves as the primary target for brain protection
strategies [7]. Astrocytes are known to play a crucial role in
supporting and protecting neuronal function as well as modulating
brain energy metabolism [8,9,10,11]. It is less well appreciated
that astrocyte mitochondria themselves play an important role in
these brain functions [8,12]. Consequently, enhancing mitochon-
drial metabolism in astrocytes is a relatively unexplored strategy to
decrease edema and preserve the penumbra [13]. Recent nuclear
magnetic resonance (NMR) spectroscopic studies detecting
astrocyte-specific mitochondrial acetate metabolism in viable and
nonviable penumbra were predictive of neuronal survival [14]. In
addition, inhibition of glial mitochondria is known to increase
astrocyte swelling and lead to oncotic cell death [15,16]. Taken
together, these reports are consistent with the hypothesis that glial
mitochondrial metabolism is a key determinant of cytotoxic
edema, necrosis and neuronal survival during cerebral ischemic
stroke.
The metabotropic IP3-mediated intracellular Ca
2+ signaling
pathway provides a very efficient mechanism to rapidly increase
mitochondrial metabolism by activation of Ca
2+ sensitive matrix
dehydrogenases [17,18]. This pathway increases the production of
intracellular ATP up to ten-fold faster than stimulation by
feedback from ADP/ATP pools [19]. IP3-mediated Ca
2+ release
in astrocytes stimulated by a variety of G-protein coupled
receptors has been well documented [20,21]. We recently
demonstrated that stimulation of G-protein coupled purinergic
receptors (P2Y1Rs) increased Ca
2+ sensitive mitochondrial metab-
olism in astrocytes [22]. We also found that the resistance of
astrocytes and co-cultured neurons to oxidative stress was
enhanced in a mitochondrial energy dependent manner [22].
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e14401Here, we have focused our investigation on the potential protective
role of P2Y1R signaling in vivo, using a Rose Bengal (RB)–induced
photothrombotic model of focal cerebral ischemia [23]. We
present evidence demonstrating that P2Y1R stimulation reduces
astrocyte cytotoxic edema, necrosis, and neuronal cell death in
mice with RB-induced brain lesions. Pharmacological and genetic
evidence indicate that P2Y1R-enhanced protection is dependent
on stimulation of astrocyte mitochondrial metabolism. These data
suggest that astrocyte mitochondria are a key energy source in the
post-ischemic penumbra, which can be stimulated by IP3-
mediated intracellular Ca
2+ release to significantly improve the
neurological outcome subsequent to brain injuries.
Results
P2Y1R Agonist 2MeSADP Decreases RB-induced Cerebral
Infarcts in Mouse
To induce an acute cerebral infarction, a small region in the
mouse parietal cortex containing multiple blood vessels was clotted
by Rose Bengal (RB) induced photothrombosis (Fig. S1). In brief,
an incision was made in the animal scalp under anesthesia to
expose the translucent skull, which was subsequently thinned and
irradiated with green light (543 nm) for ,10 minutes after tail-
vein injecting the photosensitive RB dye. When excited for
prolonged periods, RB generates singlet oxygen molecules that
locally damage the blood vessel walls and trigger thrombosis [23].
We utilized CD40 as a molecular marker to visualize the RB-
induced cerebral infarctions. CD40 is a membrane protein of the
tumor necrosis factor receptor family that has been reported to be
an early important contributor to tissue necrosis during acute
ischemic infarction [24]. Fluorescently labeled CD40 antibody
(APC-anti-mouse CD40) was tail-vein injected 16 hours prior to
imaging the necrotic tissue with a Xenogen IVIS 200 fluorescence
system. As expected for an expanding cerebral ischemic lesion, the
average magnitude of CD40 fluorescence (area6intensity) in-
creased from 5.6060.41610
8 photons/s on day 1 to 6.726
0.68610
8 photons/s on day 2, to 9.9760.75610
8 photons/s on
day 3 and to 1.3361.20610
9 photons/s on day 4 post-
photothrombosis (n=5, Fig. 1A, B).
The same experimental protocol was followed to test the
impact of P2Y1R stimulation on RB-induced brain infarctions.
Initially, the P2Y1R agonist 2MeSADP was tail-vein injected in
conjunction with RB prior to photothrombosis. We found that
the presence of 2MeSADP (100mM, 0.1ml) significantly reduced
the average size and intensity of CD40 signals to 4.3560.58610
8
photons/s on day 1, to 5.1860.22610
8 photons/s on day 2, to
5.9160.51610
8 photons/s on day 3, and to 6.6060.64610
8
photons/s on day 4 post-photothrombosis when compared to
control mice (n=5, Fig. 1A, B). No significant protective effects
were observed at lower concentrations of 2MeSADP (10 mM,
0.1ml) and administration of higher doses of 2MeSADP
(1000 mM, 0.1ml) caused respiratory inhibition and neurotox-
ocicity (see Methods). A parallel set of experiments was
performed to directly measure the size of RB-induced lesions in
brain slices stained with the vital dye 2,3,5-Tripheyltetrazolium
chloride (TTC). TTC is a colorless dye that stains healthy brain
tissue red when reduced by the mitochondrial enzyme succinyl
dehydrogenase [25]. The absence of staining in necrotic tissue is
then used to define the area of a brain infarction. As observed
with CD40 fluorescence labeling, the mean area of the RB-
induced lesion increased from 2.07 mm
360.24 (n=8) on day 1
post-photothrombosis to 2.3260.23 on day 5 in control animals
(Fig. 1F). When 2MeSADP (100 mM) was included with the RB
dye, the average size of the brain lesions was significantly reduced
to 0.86 mm
360.19 (n=9; p,0.001) on day 1 and to 1.54mm
36
0.23 (n=11, p,0.001) on day 5 (Fig. 1C–F). In a separate group
of experimental mice, 2MeSADP was injected a second time
(boosted), 24 hours after the initial injection and photothrombo-
sis. These mice exhibited the largest reduction in lesion size at
day 5, 0.77 mm
360.24 (n=7, Fig. 1E). Finally, we tested the
efficacy of 2MeSADP to reduce lesions when treatment was
delayed 24 hours after the initial photothrombosis. Remarkably,
we found that the average lesion size of this group at day 5 was
also significantly reduced to 1.2460.26 (n=6, p,0.05) compared
to untreated controls. In fact, the efficacy of 2MeSADP
introduced 24 hours after the initial photothrombosis to reduce
lesions was not significantly different from that of 2MeSADP
injected with RB dye (Fig. 1D–F).
To further investigate the impact of P2Y1R stimulation on
cerebral ischemic lesions, we performed a series of in vivo imaging
experiments utilizing transgenic mice expressing green fluorescent
protein (GFP) in astrocytes (FVB/N-Tg(GFAPGFP)14Mes/J,
JAXH Mice). The cell bodies of individual astrocytes were easily
imaged with a confocal microscope through a thinned skull
window in the parietal cortex of these mice (Fig. S1 and S2). When
a single bolus of RB was tail-vein injected, a luminal increase in
blood vessel fluorescence was transiently observed in the imaging
window. Single vessel photothrombosis could be induced by
irradiating a zoomed region of an RB-filled arteriole with green
light (543 nm) for ,5 minutes (Fig. S1D). Large mosaic images of
the cortex were then seamlessly reconstructed from ,30 individual
z-stacks to follow the effect of a single vessel clot. Twenty-four
hours after photothrombosis, an infarction border could easily be
identified by the absence (lysis) of GFP labeled astrocytes near the
clotted single vessel. The clot itself was also easy to identify by the
red fluorescence of trapped RB dye (Fig. 2A). We found that the
average size of an RB-induced lesion at 24 hours was 1.026
0.07 mm
2610
5 (n=5). This area increased to 2.1460.22 mm
2610
5 (n=5) by 48 hours. Pharmacological agents are known to
leak into local brain tissue following blood clotting due to the
disruption of the blood brain barrier (BBB). An increase in BBB
permeability was observed in these preparations as leakage of RB
dye into the extravascular space (Fig. S2). Extravasation of re-
injected RB dye from a clotted arteriole was also obvious two days
after the initial photothrombosis (Fig. S2). We took advantage of
the BBB permeability breakdown to introduce P2Y1R agonist into
the ischemic region. We determined that a tail-vein injection of
2MeSADP (100 mM) along with RB dye at the initial photo-
thrombosis significantly decreased the stroke lesion size at 24 hours
to 0.3060.02 mm
2610
5 (n=5) and to 0.5960.07 mm
2610
5 (n=5)
at 48 hours (Fig. 2D). Moreover, tail-vein injections of 2MeSADP
could again be delayed 24 hours after the initial photothrombosis
and still significantly slow the progression of the lesion. Specifically,
RB-induced lesions in both control and test mice were permitted to
expand to 0.9560.17610
5 mm
2 (n=3) and 0.8960.12 mm
2610
5
(n=3) for 24 hours, respectively (Fig. 3). The average lesion
size of mice subsequently injected with 2MeSADP was 0.886
0.15610
5 mm
2 (n=3) at 48 hours compared to 1.9760.156
10
5 mm
2 (n=3) for non-treated mice.
P2Y1R stimulation Reduces RB-induced Ischemic
Astrocyte Swelling and Necrosis
Astrocyte swelling and necrosis are considered major causes of
tissue damage after focal brain ischemia [16]. Consistent with this
etiology, we observed severely swollen astrocytes near the edge of
RB-induced infarcts with a gradient of cell swelling towards
thrombosis (Fig. 4A). Temporal imaging of perivascular astrocytes
immediately after a single RB-induced photothrombosis revealed
Energized Glia Reduce Edema
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over 6-fold within 3 hours, from 63615 mm
2 at rest to
382661 mm
2 (mean 6 SD, n=38 cells pooled from 5 mice,
Fig. 4B, C). Swelling gradually spread outward from the ischemic
core to adjacent tissue (Fig. 4A). By 24 hours, many of the swollen
astrocytes had lysed (necrosis), although some of the cells distal to
the clot exhibited reversible swelling (Fig. 4D, 6F). In contrast,
astrocyte swelling in the presence of 2MeSADP post-photothrom-
bosis was significantly reduced. At 3 hours, the average soma size
was only 99622 mm
2, and at 24 hours, many of the astrocytes
near the ischemic core had still not lysed (Fig. 4C, E). Neither laser
illumination nor the RB dye by itself affected astrocyte swelling
Figure 1. 2-MeSADP enhanced protection of Rose Bengal (RB)-induced cerebral lesions in mouse cortex. (A) Fluorescent images of RB-
induced cerebral infarcts of anesthetized mice initially treated with RB (left panels) or RB plus 2-MeSADP (right panels) on days 2, 3 and 4 after the
initial photothrombosis. RB (20 mg/ml) was illuminated at 543 nm through the cranium with a 106objective for 15 minutes on day 0. (B) Line plots of
average intensity of the RB-induced infarcts times their area are presented for each group of animals (n=4 pairs, *p,0.05, **p,0.01, ***p,0.001).
Cerebral infarcts for both animal models were fluorescently labeled with an allophycocyanin (APC)-CD40 antibody 16 hours earlier by tail vein
injection. Images were acquired on a Xenogen IVIS 200 fluorescent imaging system. (C–E) Images of coronal brain slices obtained from mice with
photothrombotic-induced cerebral infarcts on day 0 as described in Figure. 1. Brain slices were stained for live mitochondria using 2,3,5-
triphenyltetrazolium chloride (TTC) staining (Li et al., 1997) on day 1 or Day 5 as indicated. Necrotic tissue is identified in each panel (dashed
rectangles) as the absence of red staining, indicating non-respirating mitochondria. Note the significant reduction in lesion area when 2-MeSADP is
injected either at day 0 (B), at day 1 (C, left panels) or at days 0 and 1 (C, right panels). (F) Graph of average size of lesions at the indicated days. Means
are calculated from at least 5 mice for each point. **p,0.01.
doi:10.1371/journal.pone.0014401.g001
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PLoS ONE | www.plosone.org 3 December 2010 | Volume 5 | Issue 12 | e14401Figure 2. 2-MeSADP treatment decreases in vivo lesions induced by single vessel photothrombosis. (A) Mosaic reconstruction of
approximately 30 imaging fields of the parietal cortex of live transgenic mice expressing GFP in astrocytes (GFAP-GFP). The same cortical region
was imaged at day 0 (pre-photothrombosis) and at 24, 48 hours post-photothrombosis. RB was tail vein injected and irradiated (543 nm) at the
single blood vessel indicated by the open white arrows, triggering photothrombosis at 0 hours (labeled as clot in 48 hours). Astrocyte cell lysis
at 24 and 48 hours is apparent by the absence of GFP fluorescence. White dashed rectangle indicates region that is presented at higher
magnification in Fig. S4A. (B) Experimental mouse that was co-injected with RB and the P2Y1-R ligand, 2-MeSADP. Note the dramatic reduction
in the stroke lesion at 24 and 48 hours compared to panels in (A). (C) Mosaic image of day 2 panel in (A) overlaid with mosaic image of
rhodamine-dextran filled vasculature. (D) Line plots of the average lesion size of 5 control mice (RB only) and 5 experimental mice (RB+ 2-
MeSADP). **p,0.01.
doi:10.1371/journal.pone.0014401.g002
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action underlying 2MeSADP-mediated protection is its ability to
reduce astrocyte swelling and necrosis.
Functional Astrocyte Mitochondria are required for
P2Y1R-mediated decreases in RB-induced Cerebral
Infarcts
Earlier in vitro work from this laboratory demonstrated that
P2Y1R-enhanced astrocyte and neuronal protection was depen-
dent on astrocyte mitochondrial ATP production [22]. We
employed a two-fold strategy to test the in vivo impact of astrocyte
mitochondrial metabolism on P2Y1R enhanced protection. First,
we pharmacologically disrupted astrocyte mitochondrial function
by tail-vein injecting the tricarboxylic acid (TCA) cycle toxin,
fluoroacetate (100 mM, 0.1ml), prior to inducing photothrombosis.
Fluoroacetate is preferentially transported into astrocytes by
monocarboxylic acid transporter isoforms (MCT1 and 4) that
are not present in neurons [26]. When single vessels were clotted
in the presence of fluoroacetate, the average infarction size at
24 hours was significantly increased to 5.1960.28 mm
2610
5
(n=3) compared to non-treated controls (Fig. 5A, E). When
2MeSADP was co-injected with fluoroacetate, the average size of
the RB-induced lesions at 24 hours was 5.4160.14 mm
2610
5
(n=3), essentially unchanged compared to fluoroacetate only
lesions (Fig. 5A, B, E). Our second strategy was to utilize a new
transgenic mouse model that genetically disrupts mitochondrial
function by expression of a mitochondrial targeted DNA
restriction enzyme (EcoRI) under the doxycycline (dox) controlled
transactivator protein (tTA
dox off/mtEcoRI [27]). Control exper-
iments demonstrated that in the presence of dox (no tTA
expression), RB-induced lesions in GFAP-tTA-mtEcoRI mice
were indistinguishable from wildtype mice (Fig. S3 A, B) and they
were still reduced by 2MeSADP treatment (Fig. S3 C, D). We
crossed this transgenic with two mouse lines that express GFP and
tTA, respectively, under control of the astrocyte-specific transcrip-
tional promoter GFAP (GFAP-GFP-tTA
dox off-mtEcoRI). Dox was
removed from these mice for two weeks to degrade astrocyte
mitochondrial DNA and disrupt mitochondrial function [27] (Figs.
S4 and S5). Similar to our observations with fluoroacetate treated
mice, we found that the average size of lesions in mice with
degraded astrocyte mitochondrial DNA was significantly increased
to 5.2760.41610
5 mm
2 (n=3) compared to wildtype control mice
(Fig. 5C, E). Additionally, the average size of the RB-induced
lesions at 24 hours was essentially unchanged at 5.4360.506
10
5 mm
2 (n=3) when 2MeSADP was tail-vein injected (Fig. 5D,
E). We concluded from these experiments that disruption of
astrocyte mitochondrial function results in significantly larger RB-
induced lesions and that protection with the P2Y1R agonist
2MeSADP is absent.
We further tested whether disrupting mitochondrial function in
astrocytes inhibited the ability of 2MeSADP treatment to reduce
astrocyte swelling. Pharmacological inhibitors of mitochondrial
Ca
2+ uptake (Ruthenium 360), ATP synthesis (oligomycin) or
the astrocyte TCA cycle (fluoroacetate) were co-injected with
2MeSADP. Each of these inhibitors completely blocked the
ability of 2MeSADP to reduce astrocyte swelling as measured
3 hours post-photothrombosis (Fig. 6A–D). We also investigated
the ability of 2MeSADP treatment to regulate astrocyte swelling
in GFAP-GFP-tTAmtEcoRI mice that were removed from
doxycycline for 2 weeks prior to RB-induced photothrombosis.
Again, functional disruption of mitochondria in this astrocyte
specific genetic model eliminated the ability of 2MeSADP to
decrease astrocyte swelling as measured at the 3 hour time
point post-photothrombosis (Fig. 6E, F). These data suggest that
2MeSADP-induced reduction of cytotoxic edema is dependent
on astrocyte mitochondrial ATP production during ischemic
brain injuries.
Figure 3. 24 hour delayed 2-MeSADP treatment decreases the
size of cortical lesions induced by single vessel photothrom-
bosis. (A) Mosaic reconstruction of the parietal cortex from GFAP-GFP
transgenic mice imaged at day 0 (pre-photothrombosis) and at 24,
48 hours post-photothrombosis. RB was tail vein injected and a single
vessel indicated by open white arrow was irradiated (543 nm). At day 1
post-thrombosis, the P2Y1-R ligand, 2-MeSADP was tail vein injected.
Note the significant slowing of infarct progression at day 2 (lower
panel). (B) Line plot summary of 5 control (RB only) and 5 experimental
mice (RB+2-MeSADP). **p,0.01.
doi:10.1371/journal.pone.0014401.g003
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Astrocytes are known to play critical roles in neuronal
survival subsequent to both ischemic injury and brain trauma
[6,28]. Our studies have extended these findings in three
significant ways. First, we demonstrated that occlusion of single
blood vessels by photothrombosis leads to rapid cytotoxic edema
in astrocytes followed by a progressive cell lysis and brain
infarction. Second, cell swelling, necrosis and brain infarcts were
significantly reduced by treatment with the purinergic ligand
2MeSADP, which was effective when applied immediately as
well as 24 hours after the initial thrombosis. Third, our evidence
suggested that the mechanism by which 2MeSADP-reduced
both cytotoxic edema and brain infarctions was dependent on
astrocyte mitochondrial metabolism. This dependence on
mitochondrial function is consistent with an accepted underly-
ing cause of cell swelling, which is the failure of energy
dependent ion extrusion due to abrogation of oxidative
phosphorylation during hypoxia or ischemia [2,4]. It is also
interesting to note that 2MeSADP treatment 24 hours after the
initial lesion resulted in a significant reduction the TTC defined
lesion, which suggests that regions of reduced TTC staining
(i.e. the penumbra) can be rescued by energizing astrocyte
mitochondria.
Figure 4. 2-MeSADP treatment significantly reduces RB-induced post-ischemic cytotoxic swelling and necrosis of cortical
astrocytes. (A) Confocal image at the boundary of an RB-induced lesion. The white arrow indicates a gradient of astrocyte swelling nearest the
infarct 24 hours post-clot in a GFAP-GFP mouse. The insert shows a lower magnification mosaic image of cortex near the infarct, initially presented in
Fig. 3A. Dashed rectangle corresponds to higher magnification image. (B) Rapid astrocyte swelling near RB-induced photothrombosis in GFAP-GFP
transgenic mouse. The same region of the cortex was periodically imaged just prior to (0 min) and after ischemia at 30, 80, 140 min. The insert
highlights a single swollen astrocyte. (C) Lineplot of average size of astrocyte somas near clot as a function of time. The swelling is close to maximum
by 3 hours of the initial clot. Means +/2 SD (n=38 cells) pooled from 5 control RB only mice and 5 2-MeSADP treated mice. ** p,0.01 *** p,0.001
(D) High magnification images of cortical region near a blood vessel just prior to (0 hrs) and after photothombosis (3 and 24 hrs). Oncotic cell death
(the absence of green fluorescence) is apparent at 24 hours post-thrombosis, although some astrocytes further from the lesion appear to have
reversed swelling. (E) Comparable high magnification images near clotted vessel treated with 2-MeSADP. Note that astrocyte swelling proximal to the
clotted vessel is absent 3 hours post-thrombosis and that many of these cells have not lysed even at 24 hours.
doi:10.1371/journal.pone.0014401.g004
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initial osmotic swelling of cells (cytotoxic edema) that depletes the
extracellular space of Na+,C l 2 and water, followed vasogenic
edema, which appears to be primarily, but not exclusively
responsible for brain swelling [1,2,6,15,29,30]. The predominant
component that we observed in response to photothrombosis was
cytotoxic edema (Movie S1). Swelling appears to be tolerated by
the unfolding of astrocyte membranes [31,32]. Interestingly, the
magnitude of astrocyte swelling, which we estimated by the
measuring extent of GFP fluorescence, appeared to be significantly
larger than measurements previously recorded in cell culture
[31,32] or in vivo [33]. This could be due to differences in our
experimental conditions. Alternatively, our volume indicator,
expression of GFP, may not always represent the total cell volume.
In support of this, NMR measurements have indicated that the
nucleus exhibits more bulk-like water properties than the cytosol
[34]. Our pre-clot measurements of cell volume could represent a
subvolume of the cell due to the restriction of GFP fluorescence to
bulk water in the nuclear region. During cytotoxic edema, the
cytosolic increase in bulk water could then provide an expanded
environment into which GFP can freely diffuse. We also noticed
that some of the astrocytes near the edge of our infarctions
underwent reversible swelling, averting cell death at least
temporarily (Fig. 6F, Movie S2). The reversibility of astrocyte
swelling could be related to a simple increase in energy dependent
ion extrusion. An additional mechanism of action could be
stimulation of the regulatory volume decrease (RVD) [15]. Studies
in vitro have shown RVD is energy-dependent in astrocytes [35,36].
Several studies have suggested roles for P2Y1Rs in the
regulation of astrocyte swelling [37,38,39,40]. Darby and co-
workers reported that autocrine release of ATP in cultured
astrocytes leads to activation of P2Y1Rs, which in turn stimulates
the RVD [40]. On the other hand, Mongin and Kimelberg found
no requirement for autocrine ATP release for swelling induced
activation of volume regulation ion channels [38]. Uckermann and
co-workers reported that purinergic mechanism of glial swelling
inhibition was mediated by activation of A1 receptors, which
activated K+ and Cl2 channels via protein kinase A [37].
Additionally, Fujita and colleagues found that P2Y1R signaling
enhanced neuroprotection by stimulating release of IL-6 in
hippocampal cultures [39]. Our data expand the protective role
of P2Y1Rs during cytotoxic edema and suggest that 2MeSADP-
decreased swelling is mediated by stimulation of the IP3-Ca
2+
signaling pathway, ultimately increasing intracellular ATP pro-
duction in mitochondria. Increases in astrocyte Ca
2+ have also
been reported to dilate arterioles via cyclooxygenase mediated
formation of prostaglandin E2 [41,42,43]. This mechanism of
action would be expected to increase perfusion in the penumbra,
and hence, could potentially contribute to neuroprotection. In
particular, Moxon-Lexter suggested that increased perfusion
would increase the washout of lactate from hypoxic astrocytes,
thereby decreasing intracellular osmolarity and astrocyte swelling.
However, direct measurements of vessel diameters near the lesion
revealed no significant differences with or without 2-MeSADP
treatment (Fig. S7). This data suggest that neither PGE2-mediated
vasodilation nor washout of lactate play significant roles in 2-
MeSADP enhanced astrocyte protection.
Another striking morphological feature that we frequently
observed after photothrombosis was the elongation of astrocytes
extending outward from the ischemic core (Fig. S6). This radial
polarization is suggestive of fluid movement away from the lesion.
As discussed above, astrocytes are known to play a critical role in
re-establishing ion and water homeostasis post-ischemia [15,44].
Naus and co-workers also demonstrated that reduced expression of
connexin 43 in astrocytes significantly increased the size of
ischemic infarcts and they suggested that gap junctional coupling
played a critical role in the removal of ions [45,46].
Pharmacological and genetic evidence that the protective effect
of 2MeSADP is restricted to astrocyte mitochondria was presented
in Fig. 6. Ruthenium 360 (Ru360) is a relatively specific blocker of
mitochondrial Ca
2+ uptake via the Ca
2+ uniporter [47]. Impor-
tantly, it is not a toxin that blocks or inhibits mitochondrial
metabolism. It only affects processes that are dependent on Ca
2+
uptake into the mitochondria. For neurons, mitochondrial Ca
2+
rapidly results in necrotic cell death. Consequently, blocking Ca
2+
uptake with Ruthenium 360 would be expected to be protective if
neuronal mitochondria were the target. However, our data show
that Ruthenium 360 treatment blocked P2Y1R enhanced
protection, consistent with an astrocytic receptor target, presum-
ably due to stimulation of Ca
2+ sensitive matrix dehydrogenases
[17,18]. These data do not rule out an affect of 2MeSADP
treatment on vascular or microglia cells, but taken as a whole, the
data are more consistent with an astrocytic target and suggest that
mitochondrial ATP production plays a rate-limiting role in
astrocyte swelling, presumably because of the energy-dependence
of ion homeostasis.
It has been reported that 2MeSADP induces platelet aggrega-
tion in vitro and that this ligand stimulates constriction of blood
vessel segments [48]. Both effects would be expected to worsen
protection and increase ischemic injury. First, we measured the
affect of 2MeSADP treatment on vasodilation, which is normally
observed after clot formation, and found no significant difference
(Fig. S7, Table S1). Second, 2MeSADP treatment significantly
reduced the size of brain infarctions when introduced 24 hours
after the initial clot formation. Since trapped Rose-Bengal dye
within the clot was still fluorescent, we could verify the stability of
the clot at 48 hours (Fig. 3). 2MeSADP has also been reported to
have some affinity for the microglial P2Y12R, even though it is
considered a highly selective ligand for P2Y1Rs. However, it seems
unlikely that microglia mediate a significant portion of 2MeSADP
protection, since disruption of astrocyte mitochondrial function
blocks protection. Together, our data suggest that enhanced
protection cannot be attributed to affects on platelet aggregation,
vasodilation, clot stability or microglia.
Finally, we note that the focal single vessel stroke model induced
by RB-photothrombosis differs from the traditional middle
cerebral artery occlusion (MCAO) model. The ischemic volume
is significantly smaller and the pathophysiology may be more
Figure 5. Disruption of astrocyte mitochondrial metabolism increases RB-induced lesions and blocks 2-MeSADP stimulated
protection. (A and B) Mosaic image panels from the parietal cortex of fluoroacetate treated GFAP-GFP transgenic mice. Mice were imaged at day 0
(pre-photothrombosis) and at day 1 (post-photothrombosis) with (A) and without 2-MeSADP treatment (B). RB-induced photothrombosis is labeled
as clot by white arrows. Fluoroacetate, the tricarboxylic acid (TCA) cycle toxin, was injected with RB. White dashed rectangle indicates region that is
presented at higher magnification in Fig. 3B. (C and D) Mosaic image panels of GFAP-tTA-mtEcoRI-GFP mice imaged at day 0 (pre-photothrombosis)
and day 2 (post-photothrombosis) with (D) or without (C) 2-MeSADP. White dashed rectangle indicates region that is presented at higher
magnification in Fig. S3C. (E) Line plot showing average lesion sizes of fluoroacetate treated wildtype mice (3 RB only, 3 RB+2-MeSADP) and of mt-
EcoRI expressing mice (3 RB only, 3 RB+2-MeSADP). Grayed symbols and lines are from wildtype data replotted from Fig. 2D for comparison.
**p,0.01.
doi:10.1371/journal.pone.0014401.g005
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PLoS ONE | www.plosone.org 8 December 2010 | Volume 5 | Issue 12 | e14401Figure 6. Disruption of mitochondrial function blocks the reduction of post-ischemic swelling by 2-MeSADP treatment in cortical
astrocytes of GFAP-GFP mice. (A–D) High magnification confocal images of astroctyes before (0 hrs) and after (3 hrs) a single vessel
photothrombosis in wildtype mice treated with either the mitochondrial Ca
2+ uniporter inhibitor Ru360 (A), the mitochondrial ATPase inhibitor
oligomycin (B) or the mitochondrial citric acid cycle inhibitor fluoroacetate (C and D). (E) Similar high magnification images obtained from GFAP-tTA-
mtEcoRI-GFP mice. Note that significant swelling at 3 hours is observed in each case that mitochondrial function is disrupted even when treated with
2-MeSADP. (F) Confocal images of the cortical region of a GFAP-tTA-mtEcoRI-GFP mouse post-photothrombosis. Astrocytes at large distances
(.500 mm) from the ischemic core exhibit severe swelling at 3 hours. At 24 hours post-thrombosis, significant necrosis is apparent from the lack of
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but can be observed in magnetic resonance imaging (MRI) studies
[49]. The prevalence of silent strokes increases significantly in the
elderly and has been correlated with decreases in mental and
physical functioning [50]. Irrespective of the pathophysiological
correlate, data generated from this study suggest that astrocyte
mitochondrial energy metabolism is a critical determinant of the
severity of cytotoxic edema and cerebral ischemic infarcts.
Enhancement of this energy source is likely to significantly
improve the neurological outcome of multiple types of brain
injury.
Materials and Methods
Animal preparation and surgery
Male FVB/NJ mice (4–6 months), either wildtype or transgenic
(FVB/N-Tg(GFAPGFP) 14Mes/J, JAXH Mice, Bar Harbor, ME),
were used in this study. Initially, mice were anesthetized at 3%
isoflurane with 100% oxygen and subsequently maintained at 1%
isoflurane through a nosecone. Depth of anesthesia was carefully
monitored and regulated according to vital signs, pinch with-
drawal and eye blinks. Body temperature was maintained at 37uC
by a feedback-controlled heating pad (Gaymar T/Pump). Vital
signs including oxygen saturation, respiratory rate, and heart rate
were continuously monitored by using the MouseOx system
(STARR Life Sciences). The hair on the mouse head was trimmed
and a small incision was made in the scalp to expose the skull. A
custom-made stainless steel plate was glued to the skull with
VetBond Tissue Adhesive (3M, St Paul, MN). A cranial imaging
window, either open-skull or thinned-skull window, was created
over the right primary somatosensory cortex (,1.5 mm posterior
to Bregma and 2 mm lateral from midline) depending on the
experiment. For the open-skull window, a craniotomy was made
using a variable-speed electric drill (Fine Science Tools, Foster
City, California, U.S.A.) and the dura matter was carefully
removed using a dura hook. Artificial cerebrospinal fluid (aCSF)
containing 126 mM NaCl, 2.5 mM KCl, 1.25 mM NaH2PO4,
2 mM MgCl2, 2 mM CaCl2, 10 mM glucose and 26 mM
NaHCO3 (pH 7.4) was maintained on the cortical surface. For
the thinned-skull window, a large region of the skull was first
thinned with the electric drill and then further thinned with a
surgical blade. The final thickness of the thinned skull was
approximately 50 mm. Care was taken to avoid any damage to pial
vessels and underlying brain tissue. After the cranial imaging
window was created, mice were transferred to the microscope
stage and used for photothrombosis or imaging experiments. For
the repeat imaging experiments, the plate was carefully detached
from the skull and the scalp was sutured (Ethicon 6-0 silk suture).
After each experiment, the mice were either returned to cages
until the next time point or sacrificed. All procedures were
approved by the Institutional Animal Care and Use Committee
(IACUC) at University of Texas Health Science Center at San
Antonio (Animal Welfare Assurance Number: A3345-01).
Rose Bengal photothrombotic clotting and drug
application
Mice were given a 0.1ml tail-vein injection of sterilized Rose
Bengal (RB, Sigma, U.S.A.) in artificial cerebral spinal fluid
(aCSF). The RB concentration was 20 mg/ml for large lesions
(,3006300 mm
2) used for Xenogen CD40 imaging and TTC
staining experiments, and 10 mg/ml for the single arteriole
clotting experiments. Arteries on cortical surface were identified
by the blood flow direction and traced downstream to arterioles. A
targeted arteriole (20,30 mm) or cortical region was centered in
the imaging field and illuminated with a green laser (543 nm,
5mW) using a 0.8-NA 406 water-immersion objective (Nikon,
Tokyo). Clot formation was monitored in real time until the
targeted vessel or downstream capillaries were firmly occluded.
Stable clots were subsequently identified by a non-fluorescent
vessel segmentation ending with highly fluorescent regions. In
control experiments, either laser illumination or Rose Bengal itself
did not lead to clot formation. 2MeSADP (100 mM, 0.1ml) or
fluoroacetate (100 mM, 0.1ml) was induced through tail-vein
injections. The treatment concentration of 100 mM for 2MeSADP
was used for all experiments reported in this manuscript, since
lower concentrations of 2MeSADP (10 mM, 0.1ml) had no
significant effect on the lesion size (1.5860.16, mean 6 SD610
9
photons, n=6) compared to control animals (1.6660.15, n=3).
Higher dose of 2MeSADP (0.1ml, 1000 mM, 2.7 mg/kg) caused
respiratory inhibition, convulsion, tremor and seizures after
administration.
In vivo Imaging and Analysis
All images were obtained on a confocal microscope initially
using an Olympus FV500 that was later upgraded to an FV1000
MPE. As indicated, a 1060.45 NA dry, 4060.8 NA or 6061.1 NA
water objective was used. Prism software was used for two-tailed
unpaired t-test and ANOVA test. The significance level is set at
p,0.05. Data are presented as mean 6 standard error (SD) of the
mean.
Post photothrombotic infarction evaluation
The size of cerebral infarcts was evaluated 3 ways. First, a
membrane protein CD40 was used as an infarction marker [51]
and visualized using fluorescently labeled CD40 antibody
(Allophycocyanin (APC) tagged anti-mouse CD40, eBioscience)
on a Xenogen IVIS 200 fluorescent imaging system (Xenogen
Corp, Alameda,CA). A similar non-invasive visualization proce-
dure was recently published by Wunder et al. [52]. Imaging
acquisition parameters were set at 1 sec exposure time, small
binning, 8 f/stop and 6.5 cm field of view using 615–655 nm
excitation and 695–770 nm emission filters. Data were acquired
and analyzed with Living Image 2.51 software. APC-anti-mouse
CD40 was injected into the tail vein 16 hours prior to imaging.
TTC staining was evaluated at 1 and 5 days post-RB-induced-
photothrombosis. Mice were sacrificed by cervical dislocation,
their brains removed and then placed in ice cold HBSS for
3 minutes. The brain was subsequently transferred to a brain mold
(KOPF), sliced into 1 mm sections and immersed in 2% TTC
(5 min) at 37uC. The sections were fixed in 10% buffered
formaldehyde solution overnight at 4uC. Slices were imaged on
a flatbed scanner (HP Scanjet 8300) for analysis of the lesion size at
1200 dpi. The third method of evaluating the infarction was
measurement of the extent of astrocyte death, which has
previously been suggested as a determinant of the ischemic infarct
size [28]. Overlapping z-stack images were periodically obtained
around the target arteriole (60 optical sections at 2 mm z-steps)
before and after RB-induced photothrombosis as indicated.
Three-dimensional z stacks were converted into 2-dimentions
using a maximum intensity projection. A montage image of the Z-
green fluorescence. However, some astrocytes distal to the clot still undergo reversible swelling. White arrowhead identifies the same astrocyte in
each field.
doi:10.1371/journal.pone.0014401.g006
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the MosaicJ plug-in. The infarction border was identified as the
absence of GFP fluorescence. Astrocyte swelling was also
measured on the 2-dimensional projections of 3-dimensional
volumes (maximum intensity pixel projection).
Supporting Information
Figure S1 Photothrombotic model of cerebral ischemic stroke.
(A) A mouse is anesthetized and immobilized with a stainless
holders as described in methods. (B) Field of view from a dissecting
scope looking down on the mouse cranium. The skull is carefully
thinned over a 4–8 mm
2 region, which permit high resolution
confocal imaging. Small white-framed rectangle if approximate
field of view in a confocal microscope using a 106objective. (C)
Reconstructed mosaic image of the cortical region from a GFAP-
GFP mouse. Rhodamine-dextran was tail-vein injected to
illuminate vasculature. Montage was created from ,30 image
stacks (2 mm z-steps). Individual stacks were projected onto a single
image using a maximum intensity projection, then montaged
together using ImageJ plugin mosaic. (D) Higher magnification
single field images obtained with a 406objective. Lumens of the
blood vessels are filled with RB dye. Single red blood cells are
apparent as negative (dark) streaks when blood is flowing. A
precise single vessel clot (white arrow) is induced at higher zoom
(36) by irradiating with 543 nm for ,5 minutes. Subsequent
panels show development of the clot and absence of blood flow in
the final panel, indicated by white arrow.
Found at: doi:10.1371/journal.pone.0014401.s001 (1.58 MB TIF)
Figure S2 Photothrombosis breaks down the blood brain barrier
(BBB). (A) Sequential high magnification images of the mouse
cortex from GFAP-GFP mice prior to (panel 1) and after injection
of RB red fluorescent dye (bottom 3 panels). Note that the dye
clears within 30 minutes if the vessel is not clotted. (B) Same
cortical region after a second bolus of RB was tail-vein injected.
Region highlighted in panel 2a with dashed box was irradiated
with 543 nm light. After ,5 minutes, a thrombotic clot formed
(indicated by white arrow in top panel). Leakage of RB dye into
surrounding astrocytes is detectable within 10 minutes as indicated
by white arrows in the bottom 3 panels. (C) Same region of the
cortex at lower magnification, 2 days after the initial photo-
thrombosis. RB was tail-vein injected a third time. Dye leakage is
again readily apparent in the region surrounding initial clot as
indicated by white arrows.
Found at: doi:10.1371/journal.pone.0014401.s002 (3.24 MB TIF)
Figure S3 RB-induced lesions in wildtype versus GFAP-tTA-
mtEcoRI mice, in the presence of dox, are indistinguishable and
reduced by 2MeSADP treatment. (A) Fluorescent images of RB-
induced cerebral infarcts of anesthetized wildtype (left panels) and
GFATP-tTA-mtEcoRI mice (right panels) on days 2, 3 and 4 after
the initial photothrombosis. (B) Line plots of average intensity of
the RB-induced infarcts times their area are presented for each
group of animals (n=3 pairs, no significant difference). (C–D) RB-
induced cerebral infarcts in GFATP-tTA-mtEcoRI (dox on) mice
(right panels) with and without 2MeSADP. Cerebral infarcts were
fluorescently labeled with an allophycocyanin (APC)-CD40
antibody 16 hours earlier by tail vein injection. Images were
acquired on a Xenogen IVIS 200 fluorescent imaging system.
Found at: doi:10.1371/journal.pone.0014401.s003 (1.69 MB TIF)
Figure S4 Decreased levels of mtDNA in dox off GFAP-tTA-
mtEcoRI mice is specific to astrocytes. (A and B) Coronal sections
(25 mm) of hippocampal CA1 regions from control and GFAP-
tTA-mtEcoRI (dox off for 3 weeks) mice immunostained with
antibodies specific for neurons (MAP2, red) and astrocytes (GFAP,
green) and mitochondrial DNA (white, shown only at higher
magnifications). Dashed boxes designate regions of neurons (N1-3)
and astrocytes (A1-3) that are presented at higher magnification
(56zoom) in panels C–F as indicated, (C and D) Neuronal regions
N1–3 in the molecular layer of the hippocampus with merged
image of antibody labeled mtDNA (white). Insets of mtDNA
staining from single neurons are presented below each panel. (E
and F) Astrocytes A1–3 below the molecular layer with merged
images of labeled mtDNA or mtDNA by itself. (G and H)
Histograms of the frequency distribution based on the intensity of
the mtDNA summed from 6 fields for each mouse. Image J was
used to determine intensity levels using the Particle Analyzer tool.
Panels are maximum intensity projections of 8 optical sections
(2 mm steps), collected with a 406objective (1.4 NA oil immersion)
on a confocal microscope (Olympus FV1000). GraphPad Prism
software was used to plot the frequency distribution of both
neurons and astrocytes from each mouse (control and GFAP-tTA-
mtEcoRI dox off).
Found at: doi:10.1371/journal.pone.0014401.s004 (6.78 MB TIF)
Figure S5 Dox off-regulated expression of GFAP-tTA-mtEcoRI
decreases the average mitochondrial membrane potential (Dy)i n
primary cultures of astrocytes. (A) Confocal images of cultured
Astrocytes incubated with Dox (Dox on). Single mitochondria are
stained with the potential sensitive dye tetramethyl rhodamine
methyl ester (TMRM). (B) Confocal images of mitochondria in
astrocytes that have been cultured without Dox (Dox off) for 8
days. (C) Histogram plot of the distribution of Dy pooled from 12
(dox on) and 15 (dox off) cells is shifted to lower values in a
bimodal fashion when Dox is removed. Greater than 250 single
mitochondria were analyzed for each group.
Found at: doi:10.1371/journal.pone.0014401.s005 (1.46 MB TIF)
Figure S6 Radial polarization of astrocytes after focal single
vessel photothrombosis. (A–C) Higher magnification images of
the focal cortical lesions presented in Figure. 2A and Figure. 5A,
C. White dashed arrow indicates the direction to the center
of the blood clot. Image panels to the right are higher
magnifications of the regions indicated by the white dashed
rectangles.
Found at: doi:10.1371/journal.pone.0014401.s006 (3.15 MB TIF)
Figure S7 2-MeSADP treatment does not affect dilation of
blood vessels after single vessel photothrombosis. Single blood
vessel diameters were measured before and after RB-induced
photothrombosis. Average diameters at day 0 were calculated for
control and 2MeSADP-treated vessels between 20 and 39 mm, 40
to 59 mm and 60 to 79 mms. Vessel diameters on days 1 and 2
were measured and normalized with their respective day 0 value.
The average normalized percent increase times the average day 0
vessel diameter is plotted. Numerical values are presented in Table
S1. No significant differences were observed between control and
treated.
Found at: doi:10.1371/journal.pone.0014401.s007 (0.10 MB
TIF)
Table S1 The average vessel diameter of RB induced photo-
thrombosis, in the presence or absence of 2MeSADP (100 mM), on
Day 0, 1, and 2 defined by the range of pre-induction of
photothrombosis vessel diameter. Average diameters at day 0 were
calculated for control and 2MeSADP-treated vessels between 20
and 39 um, 40 to 59 mm and 60 to 79 mms. Vessel diameters on
days 1 and 2 were measured and normalized with their respective
day 0 value. The average normalized percent increase times the
average day 0 vessel diameter is shown in Figure S7.
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DOC)
Movie S1 Astrocyte swelling and oncosis near the boundary of
an ischemic core in a live mouse cortex. Confocal images were
collected on a single z-plane using a 406 objective. The region
being imagined is at the boundary of lysed and swollen cells that
define an ischemic core. Astrocytes fluorescence is due to the
expression of GFP.
Found at: doi:10.1371/journal.pone.0014401.s009 (1.51 MB
MOV)
Movie S2 Reversable astrocyte swelling distal to the ischemic
core. Confocal images were collected at a single z-plane using a
406 objective. The imaged region shows GFP-expressing
astrocytes near a blood vessel. An astrocyte endfoot process
initially swells and then shrinks.
Found at: doi:10.1371/journal.pone.0014401.s010 (2.01 MB
MOV)
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